G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,148 | -48.3% | 74,408 | -10.6% | 0.00% | – |
| Q2 2023 | $207,295 | -13.2% | 83,251 | -6.6% | 0.00% | – |
| Q1 2023 | $238,878 | +11849.9% | 89,133 | -75.8% | 0.00% | -100.0% |
| Q4 2022 | $1,999 | -100.0% | 367,969 | -21.1% | 0.00% | -50.0% |
| Q3 2022 | $5,825,000 | +119.2% | 466,430 | -13.3% | 0.00% | +100.0% |
| Q2 2022 | $2,657,000 | -38.2% | 537,987 | -5.0% | 0.00% | 0.0% |
| Q1 2022 | $4,302,000 | -19.7% | 566,011 | +7.9% | 0.00% | -50.0% |
| Q4 2021 | $5,358,000 | -32.3% | 524,733 | -11.0% | 0.00% | -33.3% |
| Q3 2021 | $7,911,000 | -66.3% | 589,331 | -44.9% | 0.00% | -57.1% |
| Q2 2021 | $23,480,000 | +15.3% | 1,070,124 | +26.6% | 0.01% | 0.0% |
| Q1 2021 | $20,373,000 | +90.8% | 845,067 | +42.4% | 0.01% | +75.0% |
| Q4 2020 | $10,677,000 | +55.5% | 593,454 | -0.2% | 0.00% | +33.3% |
| Q3 2020 | $6,867,000 | -51.2% | 594,507 | +2.5% | 0.00% | -50.0% |
| Q2 2020 | $14,076,000 | +136.0% | 580,210 | +7.2% | 0.01% | +100.0% |
| Q1 2020 | $5,965,000 | -57.5% | 541,225 | +1.8% | 0.00% | -40.0% |
| Q4 2019 | $14,045,000 | +60.3% | 531,414 | +38.3% | 0.01% | +66.7% |
| Q3 2019 | $8,761,000 | -12.7% | 384,174 | +17.3% | 0.00% | -25.0% |
| Q2 2019 | $10,039,000 | +146.9% | 327,419 | +33.7% | 0.00% | +100.0% |
| Q1 2019 | $4,066,000 | +159.0% | 244,959 | +198.8% | 0.00% | +100.0% |
| Q4 2018 | $1,570,000 | – | 81,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |